nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0744	0.193	CbGbCtD
Bromocriptine—CYP1A2—Leflunomide—systemic scleroderma	0.071	0.184	CbGbCtD
Bromocriptine—ABCB1—Lisinopril—systemic scleroderma	0.0651	0.169	CbGbCtD
Bromocriptine—ABCB1—Captopril—systemic scleroderma	0.0487	0.127	CbGbCtD
Bromocriptine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0384	0.0996	CbGbCtD
Bromocriptine—HTR2B—cardial valve—systemic scleroderma	0.0355	0.221	CbGeAlD
Bromocriptine—ABCB1—Prednisone—systemic scleroderma	0.0307	0.0797	CbGbCtD
Bromocriptine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.023	0.0597	CbGbCtD
Bromocriptine—CYP3A4—Prednisone—systemic scleroderma	0.0184	0.0477	CbGbCtD
Bromocriptine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0174	0.108	CbGeAlD
Bromocriptine—ABCB1—Methotrexate—systemic scleroderma	0.0154	0.04	CbGbCtD
Bromocriptine—HTR7—pulmonary artery—systemic scleroderma	0.0123	0.0765	CbGeAlD
Bromocriptine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0108	0.0674	CbGeAlD
Bromocriptine—HTR2A—pulmonary artery—systemic scleroderma	0.00768	0.0477	CbGeAlD
Bromocriptine—HTR1B—artery—systemic scleroderma	0.00592	0.0368	CbGeAlD
Bromocriptine—HTR1D—artery—systemic scleroderma	0.00573	0.0356	CbGeAlD
Bromocriptine—HTR1B—blood vessel—systemic scleroderma	0.00461	0.0286	CbGeAlD
Bromocriptine—HTR7—artery—systemic scleroderma	0.00457	0.0284	CbGeAlD
Bromocriptine—HTR1D—blood vessel—systemic scleroderma	0.00446	0.0277	CbGeAlD
Bromocriptine—HTR7—endothelium—systemic scleroderma	0.00386	0.024	CbGeAlD
Bromocriptine—HTR7—blood vessel—systemic scleroderma	0.00356	0.0221	CbGeAlD
Bromocriptine—HTR2A—artery—systemic scleroderma	0.00285	0.0177	CbGeAlD
Bromocriptine—HTR2A—endothelium—systemic scleroderma	0.0024	0.0149	CbGeAlD
Bromocriptine—HTR1D—connective tissue—systemic scleroderma	0.00229	0.0142	CbGeAlD
Bromocriptine—ADRB1—connective tissue—systemic scleroderma	0.00222	0.0138	CbGeAlD
Bromocriptine—HTR2A—blood vessel—systemic scleroderma	0.00222	0.0138	CbGeAlD
Bromocriptine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00195	0.0121	CbGeAlD
Bromocriptine—HTR2B—skin of body—systemic scleroderma	0.00192	0.0119	CbGeAlD
Bromocriptine—HTR7—connective tissue—systemic scleroderma	0.00182	0.0113	CbGeAlD
Bromocriptine—HTR7—smooth muscle tissue—systemic scleroderma	0.00167	0.0104	CbGeAlD
Bromocriptine—HTR2B—digestive system—systemic scleroderma	0.00154	0.00955	CbGeAlD
Bromocriptine—HTR2B—tendon—systemic scleroderma	0.00146	0.00909	CbGeAlD
Bromocriptine—ABCB1—blood vessel—systemic scleroderma	0.00145	0.00903	CbGeAlD
Bromocriptine—ADRB1—lung—systemic scleroderma	0.00134	0.00834	CbGeAlD
Bromocriptine—ADRA2A—connective tissue—systemic scleroderma	0.00134	0.00831	CbGeAlD
Bromocriptine—HTR7—digestive system—systemic scleroderma	0.00132	0.00818	CbGeAlD
Bromocriptine—HTR2B—lung—systemic scleroderma	0.00128	0.00798	CbGeAlD
Bromocriptine—HTR7—tendon—systemic scleroderma	0.00125	0.00779	CbGeAlD
Bromocriptine—ADRA2C—tendon—systemic scleroderma	0.00115	0.00716	CbGeAlD
Bromocriptine—HTR2A—connective tissue—systemic scleroderma	0.00114	0.00706	CbGeAlD
Bromocriptine—HTR7—lung—systemic scleroderma	0.0011	0.00683	CbGeAlD
Bromocriptine—CYP1A2—digestive system—systemic scleroderma	0.00105	0.00653	CbGeAlD
Bromocriptine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00104	0.00646	CbGeAlD
Bromocriptine—DRD2—lung—systemic scleroderma	0.00104	0.00646	CbGeAlD
Bromocriptine—ADRA2C—lung—systemic scleroderma	0.00101	0.00628	CbGeAlD
Bromocriptine—ADRA2A—tendon—systemic scleroderma	0.000919	0.00571	CbGeAlD
Bromocriptine—CYP1A2—lung—systemic scleroderma	0.000877	0.00545	CbGeAlD
Bromocriptine—HTR2A—digestive system—systemic scleroderma	0.000821	0.0051	CbGeAlD
Bromocriptine—ADRA2A—lung—systemic scleroderma	0.000807	0.00501	CbGeAlD
Bromocriptine—HTR2A—tendon—systemic scleroderma	0.000782	0.00486	CbGeAlD
Bromocriptine—CYP3A4—digestive system—systemic scleroderma	0.00076	0.00472	CbGeAlD
Bromocriptine—HTR2A—lung—systemic scleroderma	0.000686	0.00426	CbGeAlD
Bromocriptine—Nausea—Pentoxifylline—systemic scleroderma	0.000564	0.00124	CcSEcCtD
Bromocriptine—Infection—Mycophenolic acid—systemic scleroderma	0.000562	0.00124	CcSEcCtD
Bromocriptine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00124	CcSEcCtD
Bromocriptine—Vertigo—Lisinopril—systemic scleroderma	0.000561	0.00124	CcSEcCtD
Bromocriptine—Diarrhoea—Mometasone—systemic scleroderma	0.000561	0.00123	CcSEcCtD
Bromocriptine—Syncope—Lisinopril—systemic scleroderma	0.00056	0.00123	CcSEcCtD
Bromocriptine—Shock—Mycophenolic acid—systemic scleroderma	0.000557	0.00123	CcSEcCtD
Bromocriptine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000555	0.00122	CcSEcCtD
Bromocriptine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000555	0.00122	CcSEcCtD
Bromocriptine—Hypotension—Leflunomide—systemic scleroderma	0.000554	0.00122	CcSEcCtD
Bromocriptine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000552	0.00122	CcSEcCtD
Bromocriptine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00121	CcSEcCtD
Bromocriptine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00055	0.00121	CcSEcCtD
Bromocriptine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000549	0.00121	CcSEcCtD
Bromocriptine—Visual disturbance—Methotrexate—systemic scleroderma	0.000543	0.0012	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000542	0.00119	CcSEcCtD
Bromocriptine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000539	0.00119	CcSEcCtD
Bromocriptine—ABCB1—digestive system—systemic scleroderma	0.000538	0.00334	CbGeAlD
Bromocriptine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00118	CcSEcCtD
Bromocriptine—Insomnia—Leflunomide—systemic scleroderma	0.000536	0.00118	CcSEcCtD
Bromocriptine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000536	0.00118	CcSEcCtD
Bromocriptine—Paraesthesia—Leflunomide—systemic scleroderma	0.000533	0.00117	CcSEcCtD
Bromocriptine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00117	CcSEcCtD
Bromocriptine—Anxiety—Lisinopril—systemic scleroderma	0.00053	0.00117	CcSEcCtD
Bromocriptine—Dyspnoea—Leflunomide—systemic scleroderma	0.000529	0.00116	CcSEcCtD
Bromocriptine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000529	0.00116	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000528	0.00116	CcSEcCtD
Bromocriptine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000526	0.00116	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000525	0.00116	CcSEcCtD
Bromocriptine—Lethargy—Methotrexate—systemic scleroderma	0.000525	0.00116	CcSEcCtD
Bromocriptine—Dyspepsia—Leflunomide—systemic scleroderma	0.000522	0.00115	CcSEcCtD
Bromocriptine—Vomiting—Mometasone—systemic scleroderma	0.000521	0.00115	CcSEcCtD
Bromocriptine—Dry mouth—Lisinopril—systemic scleroderma	0.00052	0.00115	CcSEcCtD
Bromocriptine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000518	0.00114	CcSEcCtD
Bromocriptine—Rash—Mometasone—systemic scleroderma	0.000517	0.00114	CcSEcCtD
Bromocriptine—Asthenia—Captopril—systemic scleroderma	0.000516	0.00114	CcSEcCtD
Bromocriptine—Dermatitis—Mometasone—systemic scleroderma	0.000516	0.00114	CcSEcCtD
Bromocriptine—Decreased appetite—Leflunomide—systemic scleroderma	0.000516	0.00114	CcSEcCtD
Bromocriptine—Confusional state—Lisinopril—systemic scleroderma	0.000514	0.00113	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000514	0.00113	CcSEcCtD
Bromocriptine—Headache—Mometasone—systemic scleroderma	0.000513	0.00113	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000512	0.00113	CcSEcCtD
Bromocriptine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000512	0.00113	CcSEcCtD
Bromocriptine—Fatigue—Leflunomide—systemic scleroderma	0.000511	0.00113	CcSEcCtD
Bromocriptine—Oedema—Lisinopril—systemic scleroderma	0.00051	0.00112	CcSEcCtD
Bromocriptine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000508	0.00112	CcSEcCtD
Bromocriptine—Constipation—Leflunomide—systemic scleroderma	0.000507	0.00112	CcSEcCtD
Bromocriptine—Infection—Lisinopril—systemic scleroderma	0.000506	0.00112	CcSEcCtD
Bromocriptine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000504	0.00111	CcSEcCtD
Bromocriptine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000503	0.00111	CcSEcCtD
Bromocriptine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000503	0.00111	CcSEcCtD
Bromocriptine—Shock—Lisinopril—systemic scleroderma	0.000501	0.0011	CcSEcCtD
Bromocriptine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000498	0.0011	CcSEcCtD
Bromocriptine—Tachycardia—Lisinopril—systemic scleroderma	0.000497	0.0011	CcSEcCtD
Bromocriptine—Abdominal pain—Azathioprine—systemic scleroderma	0.000497	0.00109	CcSEcCtD
Bromocriptine—Body temperature increased—Azathioprine—systemic scleroderma	0.000497	0.00109	CcSEcCtD
Bromocriptine—Skin disorder—Lisinopril—systemic scleroderma	0.000495	0.00109	CcSEcCtD
Bromocriptine—Diarrhoea—Captopril—systemic scleroderma	0.000492	0.00108	CcSEcCtD
Bromocriptine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000492	0.00108	CcSEcCtD
Bromocriptine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00108	CcSEcCtD
Bromocriptine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00108	CcSEcCtD
Bromocriptine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000489	0.00108	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000489	0.00108	CcSEcCtD
Bromocriptine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000488	0.00107	CcSEcCtD
Bromocriptine—Nausea—Mometasone—systemic scleroderma	0.000487	0.00107	CcSEcCtD
Bromocriptine—Anorexia—Lisinopril—systemic scleroderma	0.000486	0.00107	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000485	0.00107	CcSEcCtD
Bromocriptine—Ataxia—Methotrexate—systemic scleroderma	0.000484	0.00107	CcSEcCtD
Bromocriptine—Constipation—Mycophenolic acid—systemic scleroderma	0.000484	0.00107	CcSEcCtD
Bromocriptine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00106	CcSEcCtD
Bromocriptine—Hypotension—Lisinopril—systemic scleroderma	0.000476	0.00105	CcSEcCtD
Bromocriptine—Dizziness—Captopril—systemic scleroderma	0.000476	0.00105	CcSEcCtD
Bromocriptine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000474	0.00104	CcSEcCtD
Bromocriptine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00104	CcSEcCtD
Bromocriptine—Urticaria—Leflunomide—systemic scleroderma	0.000471	0.00104	CcSEcCtD
Bromocriptine—Body temperature increased—Leflunomide—systemic scleroderma	0.000469	0.00103	CcSEcCtD
Bromocriptine—Abdominal pain—Leflunomide—systemic scleroderma	0.000469	0.00103	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000468	0.00103	CcSEcCtD
Bromocriptine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000466	0.00103	CcSEcCtD
Bromocriptine—Myocardial infarction—Prednisone—systemic scleroderma	0.000465	0.00102	CcSEcCtD
Bromocriptine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000464	0.00102	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000463	0.00102	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00102	CcSEcCtD
Bromocriptine—Insomnia—Lisinopril—systemic scleroderma	0.000461	0.00102	CcSEcCtD
Bromocriptine—Paraesthesia—Lisinopril—systemic scleroderma	0.000458	0.00101	CcSEcCtD
Bromocriptine—Vomiting—Captopril—systemic scleroderma	0.000458	0.00101	CcSEcCtD
Bromocriptine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000456	0.001	CcSEcCtD
Bromocriptine—Dyspnoea—Lisinopril—systemic scleroderma	0.000454	0.001	CcSEcCtD
Bromocriptine—Rash—Captopril—systemic scleroderma	0.000454	0.000999	CcSEcCtD
Bromocriptine—Dermatitis—Captopril—systemic scleroderma	0.000453	0.000998	CcSEcCtD
Bromocriptine—Somnolence—Lisinopril—systemic scleroderma	0.000453	0.000998	CcSEcCtD
Bromocriptine—Headache—Captopril—systemic scleroderma	0.000451	0.000993	CcSEcCtD
Bromocriptine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00045	0.000992	CcSEcCtD
Bromocriptine—ABCB1—lung—systemic scleroderma	0.000449	0.00279	CbGeAlD
Bromocriptine—Dyspepsia—Lisinopril—systemic scleroderma	0.000449	0.000988	CcSEcCtD
Bromocriptine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000447	0.000985	CcSEcCtD
Bromocriptine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000447	0.000985	CcSEcCtD
Bromocriptine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000983	CcSEcCtD
Bromocriptine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000444	0.000977	CcSEcCtD
Bromocriptine—Decreased appetite—Lisinopril—systemic scleroderma	0.000443	0.000976	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00044	0.000969	CcSEcCtD
Bromocriptine—Fatigue—Lisinopril—systemic scleroderma	0.000439	0.000968	CcSEcCtD
Bromocriptine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000439	0.000968	CcSEcCtD
Bromocriptine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000438	0.000964	CcSEcCtD
Bromocriptine—Constipation—Lisinopril—systemic scleroderma	0.000436	0.00096	CcSEcCtD
Bromocriptine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00096	CcSEcCtD
Bromocriptine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000955	CcSEcCtD
Bromocriptine—Bradycardia—Prednisone—systemic scleroderma	0.000434	0.000955	CcSEcCtD
Bromocriptine—Diarrhoea—Azathioprine—systemic scleroderma	0.00043	0.000946	CcSEcCtD
Bromocriptine—Nausea—Captopril—systemic scleroderma	0.000427	0.000941	CcSEcCtD
Bromocriptine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000426	0.000939	CcSEcCtD
Bromocriptine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000937	CcSEcCtD
Bromocriptine—Asthenia—Leflunomide—systemic scleroderma	0.000426	0.000937	CcSEcCtD
Bromocriptine—Hallucination—Prednisone—systemic scleroderma	0.000424	0.000934	CcSEcCtD
Bromocriptine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00042	0.000925	CcSEcCtD
Bromocriptine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000419	0.000922	CcSEcCtD
Bromocriptine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000417	0.000919	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000417	0.000918	CcSEcCtD
Bromocriptine—Dizziness—Azathioprine—systemic scleroderma	0.000415	0.000915	CcSEcCtD
Bromocriptine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000406	0.000894	CcSEcCtD
Bromocriptine—Diarrhoea—Leflunomide—systemic scleroderma	0.000406	0.000894	CcSEcCtD
Bromocriptine—Urticaria—Lisinopril—systemic scleroderma	0.000405	0.000892	CcSEcCtD
Bromocriptine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000404	0.000889	CcSEcCtD
Bromocriptine—Abdominal pain—Lisinopril—systemic scleroderma	0.000403	0.000887	CcSEcCtD
Bromocriptine—Body temperature increased—Lisinopril—systemic scleroderma	0.000403	0.000887	CcSEcCtD
Bromocriptine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000883	CcSEcCtD
Bromocriptine—Vomiting—Azathioprine—systemic scleroderma	0.000399	0.000879	CcSEcCtD
Bromocriptine—Eye disorder—Prednisone—systemic scleroderma	0.000398	0.000877	CcSEcCtD
Bromocriptine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000877	CcSEcCtD
Bromocriptine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000874	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—systemic scleroderma	0.000397	0.000874	CcSEcCtD
Bromocriptine—Rash—Azathioprine—systemic scleroderma	0.000396	0.000872	CcSEcCtD
Bromocriptine—Dermatitis—Azathioprine—systemic scleroderma	0.000396	0.000871	CcSEcCtD
Bromocriptine—Headache—Azathioprine—systemic scleroderma	0.000393	0.000867	CcSEcCtD
Bromocriptine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000393	0.000866	CcSEcCtD
Bromocriptine—Dizziness—Leflunomide—systemic scleroderma	0.000392	0.000864	CcSEcCtD
Bromocriptine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000855	CcSEcCtD
Bromocriptine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000387	0.000853	CcSEcCtD
Bromocriptine—Angiopathy—Prednisone—systemic scleroderma	0.000387	0.000851	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000849	CcSEcCtD
Bromocriptine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000841	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisone—systemic scleroderma	0.000381	0.000838	CcSEcCtD
Bromocriptine—Vomiting—Leflunomide—systemic scleroderma	0.000377	0.000831	CcSEcCtD
Bromocriptine—Alopecia—Prednisone—systemic scleroderma	0.000377	0.000829	CcSEcCtD
Bromocriptine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000374	0.000824	CcSEcCtD
Bromocriptine—Rash—Leflunomide—systemic scleroderma	0.000374	0.000824	CcSEcCtD
Bromocriptine—Dermatitis—Leflunomide—systemic scleroderma	0.000374	0.000823	CcSEcCtD
Bromocriptine—Mental disorder—Prednisone—systemic scleroderma	0.000373	0.000822	CcSEcCtD
Bromocriptine—Nausea—Azathioprine—systemic scleroderma	0.000373	0.000822	CcSEcCtD
Bromocriptine—Headache—Leflunomide—systemic scleroderma	0.000372	0.000818	CcSEcCtD
Bromocriptine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00081	CcSEcCtD
Bromocriptine—Asthenia—Lisinopril—systemic scleroderma	0.000366	0.000805	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000804	CcSEcCtD
Bromocriptine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00036	0.000792	CcSEcCtD
Bromocriptine—Rash—Mycophenolic acid—systemic scleroderma	0.000357	0.000786	CcSEcCtD
Bromocriptine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000356	0.000785	CcSEcCtD
Bromocriptine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000355	0.000781	CcSEcCtD
Bromocriptine—Headache—Mycophenolic acid—systemic scleroderma	0.000354	0.000781	CcSEcCtD
Bromocriptine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000777	CcSEcCtD
Bromocriptine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000777	CcSEcCtD
Bromocriptine—Nausea—Leflunomide—systemic scleroderma	0.000352	0.000776	CcSEcCtD
Bromocriptine—Vision blurred—Prednisone—systemic scleroderma	0.00035	0.00077	CcSEcCtD
Bromocriptine—Diarrhoea—Lisinopril—systemic scleroderma	0.000349	0.000768	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—systemic scleroderma	0.000343	0.000756	CcSEcCtD
Bromocriptine—Agitation—Prednisone—systemic scleroderma	0.000341	0.000751	CcSEcCtD
Bromocriptine—Dizziness—Lisinopril—systemic scleroderma	0.000337	0.000742	CcSEcCtD
Bromocriptine—Nausea—Mycophenolic acid—systemic scleroderma	0.000336	0.00074	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—systemic scleroderma	0.000333	0.000734	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—systemic scleroderma	0.000333	0.000733	CcSEcCtD
Bromocriptine—Syncope—Prednisone—systemic scleroderma	0.000333	0.000732	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—systemic scleroderma	0.000332	0.000731	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00033	0.000728	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—systemic scleroderma	0.000326	0.000718	CcSEcCtD
Bromocriptine—Vomiting—Lisinopril—systemic scleroderma	0.000324	0.000714	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—systemic scleroderma	0.000323	0.000711	CcSEcCtD
Bromocriptine—Rash—Lisinopril—systemic scleroderma	0.000321	0.000708	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—systemic scleroderma	0.000321	0.000708	CcSEcCtD
Bromocriptine—Dermatitis—Lisinopril—systemic scleroderma	0.000321	0.000707	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000321	0.000707	CcSEcCtD
Bromocriptine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000706	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—systemic scleroderma	0.00032	0.000705	CcSEcCtD
Bromocriptine—Headache—Lisinopril—systemic scleroderma	0.000319	0.000703	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—systemic scleroderma	0.000315	0.000693	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—systemic scleroderma	0.000315	0.000693	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000314	0.000691	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—systemic scleroderma	0.000312	0.000687	CcSEcCtD
Bromocriptine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000673	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—systemic scleroderma	0.000304	0.000668	CcSEcCtD
Bromocriptine—Nausea—Lisinopril—systemic scleroderma	0.000303	0.000667	CcSEcCtD
Bromocriptine—Oedema—Prednisone—systemic scleroderma	0.000303	0.000667	CcSEcCtD
Bromocriptine—Infection—Prednisone—systemic scleroderma	0.000301	0.000662	CcSEcCtD
Bromocriptine—Shock—Prednisone—systemic scleroderma	0.000298	0.000656	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—systemic scleroderma	0.000297	0.000654	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—systemic scleroderma	0.000295	0.000651	CcSEcCtD
Bromocriptine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00065	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—systemic scleroderma	0.000294	0.000648	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—systemic scleroderma	0.000292	0.000643	CcSEcCtD
Bromocriptine—Anorexia—Prednisone—systemic scleroderma	0.000289	0.000635	CcSEcCtD
Bromocriptine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000625	CcSEcCtD
Bromocriptine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00062	CcSEcCtD
Bromocriptine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000619	CcSEcCtD
Bromocriptine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000616	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—systemic scleroderma	0.000278	0.000613	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—systemic scleroderma	0.000274	0.000603	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—systemic scleroderma	0.000272	0.000599	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—systemic scleroderma	0.000269	0.000591	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—systemic scleroderma	0.000266	0.000587	CcSEcCtD
Bromocriptine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000584	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—systemic scleroderma	0.000263	0.000579	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000262	0.000577	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—systemic scleroderma	0.000261	0.000575	CcSEcCtD
Bromocriptine—Constipation—Prednisone—systemic scleroderma	0.000259	0.00057	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—systemic scleroderma	0.000255	0.000562	CcSEcCtD
Bromocriptine—Infection—Methotrexate—systemic scleroderma	0.000251	0.000553	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—systemic scleroderma	0.000249	0.000549	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000248	0.000546	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000248	0.000545	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—systemic scleroderma	0.000246	0.000541	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—systemic scleroderma	0.000241	0.000531	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—systemic scleroderma	0.00024	0.00053	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—systemic scleroderma	0.000239	0.000527	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—systemic scleroderma	0.000239	0.000527	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—systemic scleroderma	0.000236	0.000521	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—systemic scleroderma	0.000229	0.000504	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—systemic scleroderma	0.000227	0.0005	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—systemic scleroderma	0.000226	0.000497	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—systemic scleroderma	0.000225	0.000495	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—systemic scleroderma	0.000223	0.00049	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—systemic scleroderma	0.00022	0.000484	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000218	0.000481	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—systemic scleroderma	0.000218	0.00048	CcSEcCtD
Bromocriptine—Asthenia—Prednisone—systemic scleroderma	0.000217	0.000478	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000208	0.000459	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—systemic scleroderma	0.000207	0.000456	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000207	0.000456	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—systemic scleroderma	0.000201	0.000443	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—systemic scleroderma	0.0002	0.000441	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—systemic scleroderma	0.0002	0.00044	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—systemic scleroderma	0.0002	0.00044	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—systemic scleroderma	0.000192	0.000424	CcSEcCtD
Bromocriptine—Rash—Prednisone—systemic scleroderma	0.000191	0.00042	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—systemic scleroderma	0.000191	0.00042	CcSEcCtD
Bromocriptine—Headache—Prednisone—systemic scleroderma	0.00019	0.000418	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—systemic scleroderma	0.000182	0.0004	CcSEcCtD
Bromocriptine—Nausea—Prednisone—systemic scleroderma	0.00018	0.000396	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—systemic scleroderma	0.000173	0.000381	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—systemic scleroderma	0.000167	0.000368	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—systemic scleroderma	0.000161	0.000354	CcSEcCtD
Bromocriptine—Rash—Methotrexate—systemic scleroderma	0.00016	0.000351	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—systemic scleroderma	0.000159	0.000351	CcSEcCtD
Bromocriptine—Headache—Methotrexate—systemic scleroderma	0.000158	0.000349	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—systemic scleroderma	0.00015	0.000331	CcSEcCtD
